Want to see AU:MSX full AI Analyst Report?
Neuroscientific Biopharmaceuticals Ltd. (MSX) Ownership - Who Owns Neuroscientific Biopharmaceuticals Ltd.?
Neuroscientific Biopharmaceuticals Ltd. (MSX) Ownership Overview
- 8.24% Insiders
- 91.76% Public Companies and Individual Investors
The ownership structure of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX) stock is a mix of institutional, retail, and individual investors. , 8.24% is owned by Insiders, and 91.76% is owned by Public Companies and Individual Investors.
The ownership structure of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX) stock is a mix of institutional, retail, and individual investors. , 8.24% is owned by Insiders, and 91.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Paul Damien John Fry | 22,471,602 | Insider | 5.77% | 786,506 |
| Robert Leslie Mckenzie | 9,635,792 | Insider | 2.47% | 337,253 |
FAQ
What percentage of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX) stock is held by retail investors?
According to the latest TipRanks data, approximately 91.76% of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX) stock is held by public companies and individual investors.
Who owns the most shares of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX)?
Paul Damien John Fry owns the most shares of Neuroscientific Biopharmaceuticals Ltd. (AU:MSX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
